Global Anti-HBV Drugs Market Growth 2022-2028
The global market for Anti-HBV Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Anti-HBV Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Anti-HBV Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Anti-HBV Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Anti-HBV Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Anti-HBV Drugs players cover Sinovac Biotech, Merck, Roche, GlaxoSmithKline and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Anti-HBV Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Anti-HBV Drugs market, with both quantitative and qualitative data, to help readers understand how the Anti-HBV Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Anti-HBV Drugs market and forecasts the market size by Type (Nucleotide Analogues (NA), Interferon (IFN) and Others), by Application (Minor and Adult.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Nucleotide Analogues (NA)
Interferon (IFN)
Others
Segmentation by application
Minor
Adult
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sinovac Biotech
Merck
Roche
GlaxoSmithKline
Novartis
Bristol-Myers Squibb
Gilead Sciences
Hansoh Pharmaceutical
Genova
Chapter Introduction
Chapter 1: Scope of Anti-HBV Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Anti-HBV Drugs market size (sales and revenue) and CAGR, Anti-HBV Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anti-HBV Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anti-HBV Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anti-HBV Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sinovac Biotech, Merck, Roche, GlaxoSmithKline, Novartis, Bristol-Myers Squibb, Gilead Sciences, Hansoh Pharmaceutical and Genova, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-HBV Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-HBV Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-HBV Drugs by Country/Region, 2017, 2022 & 2028
2.2 Anti-HBV Drugs Segment by Type
2.2.1 Nucleotide Analogues (NA)
2.2.2 Interferon (IFN)
2.2.3 Others
2.3 Anti-HBV Drugs Sales by Type
2.3.1 Global Anti-HBV Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-HBV Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-HBV Drugs Sale Price by Type (2017-2022)
2.4 Anti-HBV Drugs Segment by Application
2.4.1 Minor
2.4.2 Adult
2.5 Anti-HBV Drugs Sales by Application
2.5.1 Global Anti-HBV Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-HBV Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-HBV Drugs Sale Price by Application (2017-2022)
3 Global Anti-HBV Drugs by Company
3.1 Global Anti-HBV Drugs Breakdown Data by Company
3.1.1 Global Anti-HBV Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Anti-HBV Drugs Sales Market Share by Company (2020-2022)
3.2 Global Anti-HBV Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-HBV Drugs Revenue by Company (2020-2022)
3.2.2 Global Anti-HBV Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Anti-HBV Drugs Sale Price by Company
3.4 Key Manufacturers Anti-HBV Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-HBV Drugs Product Location Distribution
3.4.2 Players Anti-HBV Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-HBV Drugs by Geographic Region
4.1 World Historic Anti-HBV Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-HBV Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-HBV Drugs Annual Revenue by Geographic Region
4.2 World Historic Anti-HBV Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-HBV Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-HBV Drugs Annual Revenue by Country/Region
4.3 Americas Anti-HBV Drugs Sales Growth
4.4 APAC Anti-HBV Drugs Sales Growth
4.5 Europe Anti-HBV Drugs Sales Growth
4.6 Middle East & Africa Anti-HBV Drugs Sales Growth
5 Americas
5.1 Americas Anti-HBV Drugs Sales by Country
5.1.1 Americas Anti-HBV Drugs Sales by Country (2017-2022)
5.1.2 Americas Anti-HBV Drugs Revenue by Country (2017-2022)
5.2 Americas Anti-HBV Drugs Sales by Type
5.3 Americas Anti-HBV Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-HBV Drugs Sales by Region
6.1.1 APAC Anti-HBV Drugs Sales by Region (2017-2022)
6.1.2 APAC Anti-HBV Drugs Revenue by Region (2017-2022)
6.2 APAC Anti-HBV Drugs Sales by Type
6.3 APAC Anti-HBV Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-HBV Drugs by Country
7.1.1 Europe Anti-HBV Drugs Sales by Country (2017-2022)
7.1.2 Europe Anti-HBV Drugs Revenue by Country (2017-2022)
7.2 Europe Anti-HBV Drugs Sales by Type
7.3 Europe Anti-HBV Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-HBV Drugs by Country
8.1.1 Middle East & Africa Anti-HBV Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-HBV Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-HBV Drugs Sales by Type
8.3 Middle East & Africa Anti-HBV Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-HBV Drugs
10.3 Manufacturing Process Analysis of Anti-HBV Drugs
10.4 Industry Chain Structure of Anti-HBV Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-HBV Drugs Distributors
11.3 Anti-HBV Drugs Customer
12 World Forecast Review for Anti-HBV Drugs by Geographic Region
12.1 Global Anti-HBV Drugs Market Size Forecast by Region
12.1.1 Global Anti-HBV Drugs Forecast by Region (2023-2028)
12.1.2 Global Anti-HBV Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-HBV Drugs Forecast by Type
12.7 Global Anti-HBV Drugs Forecast by Application
13 Key Players Analysis
13.1 Sinovac Biotech
13.1.1 Sinovac Biotech Company Information
13.1.2 Sinovac Biotech Anti-HBV Drugs Product Offered
13.1.3 Sinovac Biotech Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sinovac Biotech Main Business Overview
13.1.5 Sinovac Biotech Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Anti-HBV Drugs Product Offered
13.2.3 Merck Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Anti-HBV Drugs Product Offered
13.3.3 Roche Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Anti-HBV Drugs Product Offered
13.4.3 GlaxoSmithKline Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Anti-HBV Drugs Product Offered
13.5.3 Novartis Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb Anti-HBV Drugs Product Offered
13.6.3 Bristol-Myers Squibb Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Gilead Sciences
13.7.1 Gilead Sciences Company Information
13.7.2 Gilead Sciences Anti-HBV Drugs Product Offered
13.7.3 Gilead Sciences Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Gilead Sciences Main Business Overview
13.7.5 Gilead Sciences Latest Developments
13.8 Hansoh Pharmaceutical
13.8.1 Hansoh Pharmaceutical Company Information
13.8.2 Hansoh Pharmaceutical Anti-HBV Drugs Product Offered
13.8.3 Hansoh Pharmaceutical Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hansoh Pharmaceutical Main Business Overview
13.8.5 Hansoh Pharmaceutical Latest Developments
13.9 Genova
13.9.1 Genova Company Information
13.9.2 Genova Anti-HBV Drugs Product Offered
13.9.3 Genova Anti-HBV Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Genova Main Business Overview
13.9.5 Genova Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Anti-HBV Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-HBV Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nucleotide Analogues (NA)
Table 4. Major Players of Interferon (IFN)
Table 5. Major Players of Others
Table 6. Global Anti-HBV Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Anti-HBV Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Anti-HBV Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Anti-HBV Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Anti-HBV Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Anti-HBV Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Anti-HBV Drugs Revenue by Application (2017-2022)
Table 14. Global Anti-HBV Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Anti-HBV Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Anti-HBV Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Anti-HBV Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Anti-HBV Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Anti-HBV Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Anti-HBV Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Anti-HBV Drugs Producing Area Distribution and Sales Area
Table 22. Players Anti-HBV Drugs Products Offered
Table 23. Anti-HBV Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-HBV Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Anti-HBV Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Anti-HBV Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Anti-HBV Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Anti-HBV Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Anti-HBV Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Anti-HBV Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Anti-HBV Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Anti-HBV Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Anti-HBV Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Anti-HBV Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Anti-HBV Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Anti-HBV Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Anti-HBV Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Anti-HBV Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Anti-HBV Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Anti-HBV Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Anti-HBV Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Anti-HBV Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Anti-HBV Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Anti-HBV Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Anti-HBV Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Anti-HBV Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Anti-HBV Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Anti-HBV Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Anti-HBV Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Anti-HBV Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Anti-HBV Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Anti-HBV Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Anti-HBV Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Anti-HBV Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Anti-HBV Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Anti-HBV Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Anti-HBV Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Anti-HBV Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Anti-HBV Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Anti-HBV Drugs
Table 67. Key Market Challenges & Risks of Anti-HBV Drugs
Table 68. Key Industry Trends of Anti-HBV Drugs
Table 69. Anti-HBV Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Anti-HBV Drugs Distributors List
Table 72. Anti-HBV Drugs Customer List
Table 73. Global Anti-HBV Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Anti-HBV Drugs Sales Market Forecast by Region
Table 75. Global Anti-HBV Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Anti-HBV Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Anti-HBV Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Anti-HBV Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Anti-HBV Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Anti-HBV Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Anti-HBV Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Anti-HBV Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Anti-HBV Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Anti-HBV Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Anti-HBV Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Anti-HBV Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Anti-HBV Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Anti-HBV Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Anti-HBV Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Anti-HBV Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Anti-HBV Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Anti-HBV Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sinovac Biotech Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Biotech Anti-HBV Drugs Product Offered
Table 95. Sinovac Biotech Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Sinovac Biotech Main Business
Table 97. Sinovac Biotech Latest Developments
Table 98. Merck Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Anti-HBV Drugs Product Offered
Table 100. Merck Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Roche Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Anti-HBV Drugs Product Offered
Table 105. Roche Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. GlaxoSmithKline Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Anti-HBV Drugs Product Offered
Table 110. GlaxoSmithKline Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. GlaxoSmithKline Main Business
Table 112. GlaxoSmithKline Latest Developments
Table 113. Novartis Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Anti-HBV Drugs Product Offered
Table 115. Novartis Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Bristol-Myers Squibb Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Bristol-Myers Squibb Anti-HBV Drugs Product Offered
Table 120. Bristol-Myers Squibb Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Bristol-Myers Squibb Main Business
Table 122. Bristol-Myers Squibb Latest Developments
Table 123. Gilead Sciences Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Gilead Sciences Anti-HBV Drugs Product Offered
Table 125. Gilead Sciences Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Gilead Sciences Main Business
Table 127. Gilead Sciences Latest Developments
Table 128. Hansoh Pharmaceutical Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Hansoh Pharmaceutical Anti-HBV Drugs Product Offered
Table 130. Hansoh Pharmaceutical Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Hansoh Pharmaceutical Main Business
Table 132. Hansoh Pharmaceutical Latest Developments
Table 133. Genova Basic Information, Anti-HBV Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Genova Anti-HBV Drugs Product Offered
Table 135. Genova Anti-HBV Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Genova Main Business
Table 137. Genova Latest Developments
List of Figures
Figure 1. Picture of Anti-HBV Drugs
Figure 2. Anti-HBV Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-HBV Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-HBV Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-HBV Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nucleotide Analogues (NA)
Figure 10. Product Picture of Interferon (IFN)
Figure 11. Product Picture of Others
Figure 12. Global Anti-HBV Drugs Sales Market Share by Type in 2021
Figure 13. Global Anti-HBV Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Anti-HBV Drugs Consumed in Minor
Figure 15. Global Anti-HBV Drugs Market: Minor (2017-2022) & (K Units)
Figure 16. Anti-HBV Drugs Consumed in Adult
Figure 17. Global Anti-HBV Drugs Market: Adult (2017-2022) & (K Units)
Figure 18. Global Anti-HBV Drugs Sales Market Share by Application (2017-2022)
Figure 19. Global Anti-HBV Drugs Revenue Market Share by Application in 2021
Figure 20. Anti-HBV Drugs Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Anti-HBV Drugs Revenue Market Share by Company in 2021
Figure 22. Global Anti-HBV Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Anti-HBV Drugs Revenue Market Share by Geographic Region in 2021
Figure 24. Global Anti-HBV Drugs Sales Market Share by Region (2017-2022)
Figure 25. Global Anti-HBV Drugs Revenue Market Share by Country/Region in 2021
Figure 26. Americas Anti-HBV Drugs Sales 2017-2022 (K Units)
Figure 27. Americas Anti-HBV Drugs Revenue 2017-2022 ($ Millions)
Figure 28. APAC Anti-HBV Drugs Sales 2017-2022 (K Units)
Figure 29. APAC Anti-HBV Drugs Revenue 2017-2022 ($ Millions)
Figure 30. Europe Anti-HBV Drugs Sales 2017-2022 (K Units)
Figure 31. Europe Anti-HBV Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Anti-HBV Drugs Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Anti-HBV Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Americas Anti-HBV Drugs Sales Market Share by Country in 2021
Figure 35. Americas Anti-HBV Drugs Revenue Market Share by Country in 2021
Figure 36. United States Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Anti-HBV Drugs Sales Market Share by Region in 2021
Figure 41. APAC Anti-HBV Drugs Revenue Market Share by Regions in 2021
Figure 42. China Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Anti-HBV Drugs Sales Market Share by Country in 2021
Figure 49. Europe Anti-HBV Drugs Revenue Market Share by Country in 2021
Figure 50. Germany Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Anti-HBV Drugs Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Anti-HBV Drugs Revenue Market Share by Country in 2021
Figure 57. Egypt Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Anti-HBV Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Anti-HBV Drugs in 2021
Figure 63. Manufacturing Process Analysis of Anti-HBV Drugs
Figure 64. Industry Chain Structure of Anti-HBV Drugs
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets